2018 call for canada-israel r&d projects

summary proposal deadline: may 31, 2018

full proposal deadline: june 29, 2019

learn more: application process, guideline and template

ottawa, canada and tel aviv, israel; the canada-israel industrial r&d foundation (ciirdf) today announced the launch of a new call for proposals (cfp) for bilateral r&d projects. leveraging support from the governments of canada and israel, this cfp aims to stimulate r&d collaboration between firms in canada and israel with a focus on the commercialization of new technologies.

eligibility: this call invites private sector companies from canada and israel to propose joint research, r&d and technology development projects for the creation of innovative products or processes with a non-defense application. preference will be given to small and medium sized enterprises (firms with fewer than 500 employees). the maximum length for projects funded under this call is 24 months.

• canadian firms can leverage academic expertise on their r&d project and engage 世界杯2022赛程表淘汰赛 jointly with the natural sciences and engineering research council (nserc).
• public sector organizations, such as universities and research institutions, are eligible to participate in r&d projects as project subcontractors or consultants (not applicants)

funding: following a rigorous evaluation process, ciirdf selects and awards canada-israel r&d teams with financial contributions up to 50 percent of the eligible project costs to a maximum of cdn$ 800,000 per project.

areas of special consideration: special consideration will be given to projects in the following areas:

• information and communication technologies (including cyber, fintech)
• life sciences
• aerospace
• clean tech and sustainable tech (including water, renewables), plus limited energy (oil and gas)
• agriculture and agrifood (including agri-tech)

for additional information, please contact:

• tomoko nishino, ciirdf canada: tomoko@ciirdf.ca

avner montemayor, ciirdf israel: amontemayor@ciirdf.ca

the genomic applications partnership program (gapp) funds downstream research and development (r&d) projects that address real world opportunities and challenges identified by industry, government, not-for-profits and other “receptors” of genomics knowledge and technologies.

gapp projects are collaborations between academic researchers and receptor organizations. they are co-funded by receptors and other stakeholders, and have the potential to generate significant social and/or economic benefits for canada.

the 2018 ontario-israel research network program – magnet (oirnp-magnet) call for proposals focuses on smart mobility technologies. ontario small and medium-sized enterprises (smes), in partnership with israeli smes, will develop industrial or collaborative r&d technologies that address the smart mobility needs of a participating anchor company (ac), strengthening both ontario and israel’s technological expertise while enhancing global competitiveness. ontario-based multinational enterprises (mnes) interested in developing smart mobility technologies will act as anchor companies to provide guidance and resources appropriate to a successful outcome over the term of the project.

each application must address at least one of the priority areas identified by the anchor companies. projects must include at least one sme from ontario, one sme from israel and, for the current call, one partnering multinational enterprise (mne) from ontario acting as an anchor company (ac). ontario applicants are also strongly encouraged to collaborate with researchers from publicly-funded post-secondary institutions.

the canadian cancer society (ccs) in partnership with the chordoma foundation is issuing a special grant award focused on a rare cancer that occurs in the bones of the skull base and spine, called chordoma. as a result of a fundraising partnership with the chordoma foundation and generous donors, there is funding available to support up to 2 meritorious applications that will impact our understanding of chordoma and generate new ideas leading to critically needed systemic therapies. it is hoped that this grant award will utilize innovative technologies and foster new collaborations in order to drive translational research findings rapidly to the clinic.

applications that build new collaborations and capacity in chordoma research are encouraged.

to be eligible, you must meet the following requirements:

• you must be a citizen or permanent resident of canada, or a citizen of a developing country.
• you must be enrolled at a canadian university at the doctoral level (when you submit your application, you must have completed several courses of the doctoral program, but not necessarily all of the courses).
• your research proposal must be approved by your thesis supervisor. please provide proof.
• your proposed field research must take place in one or more developing countries and be conducted for a doctoral dissertation.
• your field research must correspond to idrc thematic priorities. applications proposing field research outside these thematic areas will not be considered.
• you must provide evidence of affiliation with an institution or organization in the developing region(s) in which the research will take place.
• you must have completed coursework and passed comprehensive exams before taking up the award.
• you may not be in receipt of two or more active idrc awards at the same time. no time overlaps will be permitted.

currently open: 2018/19 targeted call program for patient-oriented research on health system integration and performance (porhsip) - prospective evaluation research notice of intent and full application submissions
launch date: march 29, 2018
notice of intent deadline: april 26, 2018
full application deadline: june 4, 2018

• overview
• notice of intent
• full application
• review process of full applications
• application instructions
• resources
• current grants funded through hsrf targeted calls

overview

the purpose of the hsrf targeted calls is to solicit and fund focused research applications within mohltc priority areas. the two new calls focus on patient-oriented research in mental health and addictions and patient-oriented research on health system integration and performance.

for the targeted call for patient-oriented research in mental health and addictions:
for each of the priority areas, key knowledge gaps related to current/anticipated policy development and program development were identified as targeted research areas of interest for policy makers and knowledge users through a consultative process. refer to the full application for definitions of targeted research priority areas and sub-priority areas.

for the targeted call program for patient-oriented research on health system integration and performance (porhsip) - prospective evaluation research:
refer to the full application for definitions of targeted research sub-priority areas.

applicants will be assessed on the extent to which sex and gender have been considered in their proposed research (i.e., rationale, methods and knowledge translation and exchange (kte) plan). additionally, applicants will be assessed on the extent to which patients have been meaningfully engaged in the proposed research.

five additional cross-cutting components have also been identified for hsrf awards (excluding the targeted call program for porhsip). applicants are encouraged to incorporate any/all of these components into their projects where applicable and/or feasible. these cross-cutting components are:

• equity
• indigenous health
• patient-centred care
• implementation science
• modernizing patient-centred care through digital health

refer to the hsrf guidelines for definitions and selected examples of government initiatives and commitments related to each cross-cutting component.

for the hsrf targeted call program for porhsip, the project includes consideration of health equity (populations in the heia and supplements), indigenous, french language lenses as well as sex (biologic) and gender (social) analysis.

patients first: action plan for healthcare outlines the ministry's commitment to expand how patients are engaged throughout the health care system. to meet this commitment, the ministry is also expanding the patient engagement component of all hsrf calls. all research funded through the hsrf must include meaningful patient engagement to ensure the patient's perspective is considered in all aspects of a research project.

the adopting research to improve care (artic) program is a proven model for accelerating the implementation of research evidence into broader practice, contributing to improving the quality of care across ontario. it is a continuing partnership co-led by health quality ontario (hqo) and the council of academic hospitals of ontario (caho) and brought to life through the program’s engagement with a wide array of system partners.

overview

each year, the artic program selects one or more projects to receive the funding and supports that the program provides. the projects that are selected will use all components of the established artic model to support the implementation of clinical interventions or practice changes at multiple sites (“spread partners”) across the province.

theme for 2018 call

the overarching theme for the 2018 call is adopting hqo quality standards, specifically in the following areas of need
o behavioral symptoms of dementia
o schizophrenia care for adults in hospitals
o major depression
o heavy menstrual bleeding
o hip fracture
o wound care (diabetic foot ulcers)
o wound care (venous leg ulcers)
o wound care (pressure injuries)
o opioid use disorder (opioid addiction)
o opioid prescribing for acute pain
o opioid prescribing for chronic pain
o palliative care

the aim of the joint call is to enable scientists in different countries to build an effective collaboration on a common interdisciplinary collaborative research project (crp) based on complementarities and sharing of expertise, with a clear translational research approach.

the specific objective of this joint call is to advance gender equality in research through institutional change and to foster the integration of sgba into research, contents and funding programmes.

for more information, please consult the gender-net plus website.

the overall aim of the call is to fund projects showing clinical feasibility of pm in complex diseases (including multifactorial, monogenic and other diseases). by feasibility is meant the demonstration of significant and clinically relevant improvement of current diagnostics and/or therapeutics, based on improved understanding of underlying molecular mechanisms. applicants are expected to combine pre-clinical and/or clinical research with bio-informatics components to enable data quality on one side and the potential applicability for health care providers on the other side.

this should be based on methods that are possible to use in and/or be further developed for clinical, general practice and public health settings. this may involve validation of known biomarkers, interoperable data solutions and software for decision support for healthcare providers. integration of other sources of clinically relevant data in the clinical decision support, such as imaging or routine data, could also be considered to improve the diagnostic predictions. the projects could include exploratory clinical studies that demonstrate the feasibility of early diagnosis and/or stratification of patients for existing drugs. larger clinical trials, for example for the identification of novel drugs, are beyond the scope of the call. because understanding of molecular mechanisms in complex/multifactorial diseases but also other diseases (such as monogenic, rare diseases and cancer) involves multiple genes, gene products or regulators, it is likely that omics methods are required, as are in vitro or in vivo validation studies.

the era permed call is expected:

• to support translational research projects in the field of personalized medicine;
• to encourage and enable interdisciplinarity, in combining pre-clinical and/or clinical research with computational components.

for more information, please consult the ic permed international consortium website.